These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

311 related items for PubMed ID: 3537801

  • 1. Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial.
    Eschbach JW, Egrie JC, Downing MR, Browne JK, Adamson JW.
    N Engl J Med; 1987 Jan 08; 316(2):73-8. PubMed ID: 3537801
    [Abstract] [Full Text] [Related]

  • 2. Correction of anaemia in haemodialysis patients with recombinant human erythropoietin.
    Boran M, Dalva I, Yazicioğlu A, Akbay E, Cetin S.
    Int Urol Nephrol; 1993 Jan 08; 25(2):197-203. PubMed ID: 8365853
    [Abstract] [Full Text] [Related]

  • 3. [Erythropoietin--the first hematologic hormone in clinical use].
    Rhyner K.
    Schweiz Med Wochenschr; 1988 Mar 19; 118(11):375-80. PubMed ID: 3287601
    [Abstract] [Full Text] [Related]

  • 4. Clinical efficacy of recombinant human erythropoietin in hemodialysis patients.
    Mohini R.
    Semin Nephrol; 1989 Mar 19; 9(1 Suppl 1):16-21. PubMed ID: 2648516
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Effect of the treatment with human recombinant erythropoietin on anemia in children with end-stage kidney failure. French multicenter study].
    Sinnassamy P, Andre JL, Treize G, Leroy B.
    Arch Fr Pediatr; 1993 Mar 19; 50(3):201-8. PubMed ID: 8338412
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effect of recombinant human erythropoietin on the anemia of chronic renal failure.
    Urabe A, Takaku F, Mizoguchi H, Kubo K, Ota K, Shimizu N, Tanaka K, Mimura N, Nihei H, Koshikawa S.
    Int J Cell Cloning; 1988 May 19; 6(3):179-91. PubMed ID: 3397592
    [Abstract] [Full Text] [Related]

  • 9. Treatment of the anemia of progressive renal failure with recombinant human erythropoietin.
    Eschbach JW, Kelly MR, Haley NR, Abels RI, Adamson JW.
    N Engl J Med; 1989 Jul 20; 321(3):158-63. PubMed ID: 2747747
    [Abstract] [Full Text] [Related]

  • 10. [Human recombinant erythropoietin (rH-EPO) in chronic hemodialysis patients].
    Jalil R, Vaccarezza A, Jara A, Lira P, Vial S, Serrano V.
    Rev Med Chil; 1990 Jun 20; 118(6):629-34. PubMed ID: 1775783
    [Abstract] [Full Text] [Related]

  • 11. National cooperative rHu erythropoietin study in patients with chronic renal failure: a phase IV multicenter study. Report of National Cooperative rHu Erythropoietin Study Group.
    Nissenson AR.
    Am J Kidney Dis; 1991 Oct 20; 18(4 Suppl 1):24-33. PubMed ID: 1928075
    [Abstract] [Full Text] [Related]

  • 12. Who should receive recombinant human erythropoietin?
    Van Stone JC.
    Semin Nephrol; 1989 Mar 20; 9(1 Suppl 2):3-7. PubMed ID: 2669084
    [Abstract] [Full Text] [Related]

  • 13. [Effectiveness of recombinant human erythropoietin in the treatment of transfusion-dependent anemia in patients on chronic dialysis].
    Graf H, Mayer G, Cada EM, Thum J, Stummvoll HK.
    Wien Klin Wochenschr; 1987 Dec 18; 99(24):855-9. PubMed ID: 3439185
    [Abstract] [Full Text] [Related]

  • 14. The use of recombinant human erythropoietin (EPO) to correct the anemia of end-stage renal disease: a progress report.
    Adamson W, Egrie JC, Browne JK, Downing MR, Eschbach W.
    Behring Inst Mitt; 1988 Aug 18; (83):188-92. PubMed ID: 3071336
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Dose-related effects of recombinant human erythropoietin on erythropoiesis. Results of a multicenter trial in patients with end-stage renal disease.
    Bommer J, Kugel M, Schoeppe W, Brunkhorst R, Samtleben W, Bramsiepe P, Scigalla P.
    Contrib Nephrol; 1988 Aug 18; 66():85-93. PubMed ID: 3292151
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Investigation of the efficacy of a biogeneric recombinant human erythropoietin alfa in the management of renal anemia in patients on hemodialysis: a multi-center clinical trial.
    Beiraghdar F, Panahi Y, Einollahi B, Nemati E, Ghadiani MH, Sahebkar A, Maghsoudi N, Marzony ET.
    Clin Lab; 2012 Aug 18; 58(7-8):737-45. PubMed ID: 22997974
    [Abstract] [Full Text] [Related]

  • 20. Recombinant human erythropoietin treatment: investigational new drug protocol for the anemia of the acquired immunodeficiency syndrome. Overall results.
    Phair JP, Abels RI, McNeill MV, Sullivan DJ.
    Arch Intern Med; 1993 Dec 13; 153(23):2669-75. PubMed ID: 8250662
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.